Group 1 - Maduro denies all charges from the U.S. and claims he is still the President of Venezuela [2] - The U.S. has accused Maduro of drug terrorism conspiracy, cocaine smuggling conspiracy, and possession of firearms [2] - Maduro states he was forcibly taken from his home in Caracas [2] Group 2 - China condemns the U.S. for violating Venezuela's sovereignty and international principles [3] - The U.S. is accused of undermining multilateralism and threatening peace in Latin America and the Caribbean [3] Group 3 - Venezuela's oil exports have nearly dropped to zero due to U.S. sanctions and blockade [4] - The Venezuelan oil company is reducing production and closing some oil fields due to accumulated inventory [4] - Shortages of diluents for blending heavy crude oil are further restricting production activities [4] Group 4 - Trump claims the U.S. must have complete access to Venezuela's resources and asserts U.S. control over the country [5][6] - The U.S. Vice President's residence was attacked, with one suspect arrested [6] Group 5 - High expectations for Chinese stocks with projected annual growth of 15% to 20% in 2026 and 2027 [8] - Corporate earnings in China are expected to grow by 14% and 12% in 2026 and 2027, respectively [8] - Factors driving growth include AI applications, international expansion, and policies to reduce internal competition [8]

Group 1 - The core point of the article is that Nantong Chaoda Equipment Co., Ltd. has not yet implemented its previously disclosed share repurchase plan as of December 31, 2025 [1][3] Group 2 - The share repurchase plan was approved by the board on October 27, 2025, with a total funding amount between 25 million yuan and 50 million yuan, and a maximum repurchase price of 65.44 yuan per share [2] - The implementation period for the repurchase plan is within 12 months from the board's approval, ending on October 26, 2026 [2] Group 3 - The company will continue to assess market conditions to implement the repurchase plan within the specified timeframe and will fulfill its information disclosure obligations as required by regulations [4]

Core Viewpoint - Shandong Guocer Functional Materials Co., Ltd. announced the progress of its share repurchase plan, which has not yet been implemented as of December 31, 2025, and will proceed based on market conditions within the designated timeframe [1][3]. Group 1: Repurchase Plan Overview - The company approved a share repurchase plan on November 6, 2025, intending to use its own and raised funds to repurchase shares through centralized bidding, aimed at employee stock ownership plans or equity incentive plans [2]. - The total amount allocated for the repurchase is set between 100 million yuan (inclusive) and 200 million yuan (inclusive), with a maximum repurchase price of 30 yuan per share (inclusive) [2]. - The implementation period for the repurchase is up to 12 months from the board's approval date, concluding by November 5, 2026, and does not require shareholder meeting approval [2]. Group 2: Current Status and Future Plans - As of the end of December 2025, the company has not executed the share repurchase as per the regulations of the Shenzhen Stock Exchange [3]. - The company plans to continue the repurchase according to market conditions and will fulfill its information disclosure obligations as required [4]. - Market analysts view the implementation of the repurchase plan as a recognition of the company's value, which may provide support for the company's stock price [4].

登录新浪财经APP 搜索【信披】查看更多考评等级 无锡洪汇新材料科技股份有限公司（以下简称"无锡洪汇新材"）于2026年1月6日发布回购股份进展公 告，披露了截至2025年12月31日的股份回购实施情况。公告显示，公司已通过集中竞价方式启动股份回 购，资金来源为自有资金，且回购价格未超过此前设定的15.90元/股上限，符合既定回购方案及相关监 管要求。 回购方案回顾：拟斥资1000万至2000万元回购注销股份 据公告披露，无锡洪汇新材于2025年8月15日召开第六届董事会第二次会议，随后在2025年9月5日召开 的2025年第二次临时股东会上，均审议通过了《关于以集中竞价方式回购股份方案的议案》。根据该方 案，公司计划使用自有资金以集中竞价交易方式回购股份，全部用于注销并减少公司注册资本。 具体来看，本次回购的资金总额区间为不低于1000万元（含）且不超过2000万元（含），回购价格上限 为15.90元/股（含）。按此价格上限测算，预计回购股份数量约为62.89万股至125.79万股，约占公司当 前总股本的0.34%至0.69%。回购实施期限为自股东会审议通过之日起不超过6个月，即截至2026年3月5 日。 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 浙江金固股份有限公司（下称"金固股份"）于2026年1月5日发布股份回购进展公告，披露截至2025年12 月31日，公司此前披露的3000万元至6000万元股份回购计划尚未实施，主要原因是正在办理开立回购专 用证券账户等事宜。 回购方案回顾：拟斥资3000万至6000万元，用于员工持股或股权激励 据公告回溯，金固股份于2025年12月9日召开第六届董事会第十五次会议，审议通过了《关于回购公司 股份方案的议案》。根据该方案，公司计划使用自有资金及自筹资金，以集中竞价方式回购公司股份， 回购股份拟用于实施员工持股计划或股权激励。 金固股份在公告中表示，后续将根据《上市公司股份回购规则》《深圳证券交易所上市公司自律监管指 引第9号——回购股份》的相关规定及公司股份回购方案，在回购期限内推进回购事宜，并严格履行信 息披露义务。同时，公司提醒广大投资者注意投资风险。 本次回购计划是金固股份基于对公司未来发展的信心及价值判断，旨在通过回购股份用于员工激励，进 一步完善公司治理结构，调动员工积极性。市场将持续关注公司回购专用证券账户办理进度及后续回购 实施情况。 声明：市场 ...

Core Viewpoint - Yipinhong Pharmaceutical Group Co., Ltd. has announced the progress of its share repurchase plan, indicating that as of December 31, 2025, it has repurchased 2.6932 million shares, accounting for 0.60% of its total share capital, with a total expenditure of 93.8909 million yuan, nearing the lower limit of the repurchase plan of 100 million yuan [1][3]. Group 1: Repurchase Plan Background - The board of directors approved a share repurchase plan on December 15, 2025, intending to use self-owned and/or raised funds to repurchase A-shares through centralized bidding to maintain company value and shareholder rights [2]. - The repurchase plan sets a total fund range of no less than 100 million yuan and no more than 200 million yuan, with a maximum repurchase price of 70 yuan per share, and the implementation period is within three months from the board's approval [2]. Group 2: Repurchase Progress Details - As of December 31, 2025, the company has repurchased 2.6932 million shares through a dedicated securities account via centralized bidding, with the highest transaction price at 37.72 yuan per share, the lowest at 32.15 yuan per share, and an average transaction price of 34.86 yuan per share, totaling 93.8909 million yuan spent (excluding fees) [3]. - The repurchase actions comply with the established plan and relevant legal regulations, adhering to trading time and other restrictions as per the regulations [3]. Group 3: Future Arrangements - The company plans to continue implementing the share repurchase plan based on market conditions within the designated period and will fulfill its information disclosure obligations as required by laws and regulations [4]. - The implementation of this repurchase plan reflects the company's recognition of its value and confidence in future development, aiming to maintain shareholder rights and stabilize market expectations [4].

2025年11月18日，公司董事会审议通过延长回购期限的议案，将原截止日期（2025年11月19日）延长3 个月，调整后回购实施截止日期为2026年2月19日，方案其他内容未发生变化。 截至12月底回购进展 浙江景兴纸业股份有限公司（以下简称"景兴纸业"）于2026年1月6日发布回购股份进展公告，披露截至 2025年12月31日的股份回购实施情况。公告显示，公司已累计完成最高额度回购，且回购期限已延长至 2026年2月19日。 回购方案及期限调整 回溯公告信息，景兴纸业于2024年10月30日召开董事会、监事会，同年11月19日经临时股东大会审议通 过回购方案。根据方案，公司计划在12个月内使用自有或自筹资金，以不超过4.00元/股的价格回购股 份，资金规模为8,000万元至15,000万元，回购股份拟用于转换公司发行的可转换债券。 公告显示，截至2025年12月31日，公司通过股份回购专用证券账户以集中竞价交易方式累计回购股份， 最高成交价为4.00元/股，未超过方案设定的价格上限。本次回购符合《上市公司股份回购规则》《深 圳证券交易所上市公司自律监管指引第9号——回购股份》等相关规定。 合规性说明与后续安 ...

Group 1: Company Overview - Company held a specific investor meeting on January 5, 2026, in Shanghai, attended by nine institutions including Tianfeng Securities and Southern Fund [1][2] - Senior Vice President and Secretary of the Board, Chen Feibiao, along with Securities Affairs Representative Dai Yiyi, discussed key issues such as the progress in the new energy business, overseas base layout, and pharmaceutical business planning [1][2] Group 2: New Energy Business - The new energy business is focused on the sales of LiFSI and electrolyte products, with a breakthrough in revenue achieved in 2025 and expected continued growth in 2026 [2] - The lithium hexafluorophosphate project is currently in the technical improvement stage, with ongoing optimization of product competitiveness through systematic process development [2] - The company leverages its long-standing experience in chemical synthesis to enhance its market position in the new energy sector [2] Group 3: Overseas Operations - The UK production base is operating smoothly in 2026, while the Malaysian base is under phased construction, primarily aimed at producing agricultural CDMO products [3] - The company plans to integrate resources from China, the UK, and Malaysia to provide comprehensive supply chain solutions covering the entire product lifecycle [3] Group 4: Pharmaceutical Business - The pharmaceutical business focuses on a CDMO model and has established partnerships with several leading global pharmaceutical companies, while also expanding its client base [4] - The business primarily serves products under patent, with long-term growth expected as these products are promoted [4] - Future development will emphasize small molecule CDMO, starting materials, and registration materials, while also investing in emerging areas such as peptides and radiopharmaceuticals [4] Group 5: Risk Management - The company acknowledges potential revenue impacts from the expiration of patents for agricultural clients but plans to mitigate this through product and technology upgrades [6]

Core Viewpoint - Longbai Group has initiated a share repurchase plan with a total budget of 500 million to 1 billion RMB, aimed at employee stock incentives and shareholding plans, and is progressing as scheduled [1][2]. Group 1: Repurchase Plan Overview - The repurchase plan was approved on June 6, 2025, allowing the company to use its own funds and special loans to repurchase A-shares through centralized bidding [2]. - The total repurchase amount is set between 50 million RMB and 100 million RMB, with the maximum repurchase price adjusted from 24.82 RMB to 24.22 RMB per share due to equity distributions [2]. - The implementation period for the repurchase is 12 months from the board's approval, ending on June 5, 2026 [2]. Group 2: Progress as of December End - As of December 31, 2025, the company has successfully executed share repurchases in accordance with the established plan and relevant regulations [3]. Group 3: Compliance Statement - Longbai Group has confirmed that the share repurchase strictly adheres to regulatory requirements, including not repurchasing shares during significant events that could impact stock prices [4]. Group 4: Future Arrangements - The company plans to continue the share repurchase based on market conditions and will fulfill its information disclosure obligations during the repurchase period [5].

登录新浪财经APP 搜索【信披】查看更多考评等级 公告明确，公司后续实施回购时，将规避可能影响股价的敏感时段。具体包括：自可能对公司证券交易 价格产生重大影响的重大事项发生之日或决策过程中，至依法披露之日内，不实施回购；同时，中国证 监会和深交所规定的其他情形也在禁止回购期间之列。 按照监管要求，上市公司在回购股份期间，需于每月前三个交易日内公告截至上月末的回购进展。此次 披露的便是截至2025年12月末的具体情况。 进展披露：截至去年末尚未启动，专用账户未操作 根据公告，截至2025年12月31日，公司回购专用证券账户尚未开始实施回购。这意味着，在回购方案经 董事局和股东会审议通过近四个月后，实际操作仍未启动。 对于尚未启动的原因，公告未作具体说明，仅表示后续回购的时间、数量、价格及集中竞价交易委托时 段，将严格遵照《深圳证券交易所上市公司自律监管指引第9号——回购股份》等相关规定执行。 后续安排：将严格遵守监管要求，适时推进回购 2026年1月6日，陕西金叶科教集团股份有限公司（下称"陕西金叶"）发布回购股份进展情况公告，披露 截至2025年12月31日，公司回购专用证券账户尚未开始实施股份回购。这一进展 ...